- Home
- PHGE vs MTR Comparison
PHGE vs MTR Comparison
Compare PHGE & MTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHGE
- MTR
- Stock Information
- Founded
- PHGE 2015
- MTR 1979
- Country
- PHGE Israel
- MTR United States
- Employees
- PHGE N/A
- MTR N/A
- Industry
- PHGE Biotechnology: Pharmaceutical Preparations
- MTR Oil & Gas Production
- Sector
- PHGE Health Care
- MTR Energy
- Exchange
- PHGE Nasdaq
- MTR Nasdaq
- Market Cap
- PHGE 10.4M
- MTR 10.9M
- IPO Year
- PHGE N/A
- MTR N/A
- Fundamental
- Price
- PHGE $0.52
- MTR $5.58
- Analyst Decision
- PHGE Strong Buy
- MTR
- Analyst Count
- PHGE 1
- MTR 0
- Target Price
- PHGE $15.00
- MTR N/A
- AVG Volume (30 Days)
- PHGE 991.6K
- MTR 2.9K
- Earning Date
- PHGE 08-13-2025
- MTR 01-01-0001
- Dividend Yield
- PHGE N/A
- MTR 3.78%
- EPS Growth
- PHGE N/A
- MTR N/A
- EPS
- PHGE N/A
- MTR 0.21
- Revenue
- PHGE N/A
- MTR $580,337.00
- Revenue This Year
- PHGE N/A
- MTR N/A
- Revenue Next Year
- PHGE N/A
- MTR N/A
- P/E Ratio
- PHGE N/A
- MTR $26.36
- Revenue Growth
- PHGE N/A
- MTR N/A
- 52 Week Low
- PHGE $0.34
- MTR $4.70
- 52 Week High
- PHGE $1.23
- MTR $10.42
- Technical
- Relative Strength Index (RSI)
- PHGE 50.56
- MTR 48.24
- Support Level
- PHGE $0.49
- MTR $5.51
- Resistance Level
- PHGE $0.56
- MTR $5.60
- Average True Range (ATR)
- PHGE 0.04
- MTR 0.13
- MACD
- PHGE -0.01
- MTR -0.00
- Stochastic Oscillator
- PHGE 49.28
- MTR 77.66
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).
About MTR Mesa Royalty Trust
Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.